India approves Russia's 'Sputnik V' COVID-19 vaccine: Economic Times

FILE PHOTO: A medical worker prepares a dose of the Sputnik V vaccine against the coronavirus disease (COVID-19) in Caracas, Venezuela April 9, 2021. REUTERS/Leonardo Fernandez Viloria

BENGALURU (Reuters) - India has approved the use of Russia's "Sputnik V" vaccine against COVID-19 based on strong immunogenicity data, the Economic Times newspaper reported on Monday.

It would be the third COVID-19 vaccine approved in India after AsztraZeneca's Covishield, and local firm Bharat Biotech's COVAXIN.

India's drugs regulator will give the final go-ahead for the "Sputnik V" rollout, the Economic Times reported. (

India is battling a massive second wave of COVID-19 infections, with more than 13.5 million cases. The country of 1.3 billion surpassed Brazil on Monday to become the world's second worst affected country by COVID-19.

"Sputnik V" is being marketed in India by Dr. Reddy's Laboratories, which has helped run a small trial for the drug in the country to test its safety and ability to generate an immune response.

Neither Dr. Reddy's nor India's drugs regulator had any immediate comment when contacted by Reuters.

"Sputnik V", developed by Moscow's Gamaleya Institute, has proved 91.6% effective against COVID-19 and has been approved for use in more than 50 countries.

(Reporting by Sachin Ravikumar in Bengaluru and Krishna Das in New Delhi; Editing by Vinay Dwivedi)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3

Next In World

Removal of all contractors from Afghanistan underway -Pentagon chief
Immigration in focus at high level U.S.-Mexico talks on Friday
Pint-sized Mongolian menace shows dinosaurs loved the nightlife, too
Morocco recalls its ambassador to Berlin over Western Sahara
Global COVID-19 death toll more than double official estimates - IHME
Canada promises two Arctic icebreakers in pre-election job boost
Factbox: Groups that Russia has declared extremist
UK navy vessels to return to port from Jersey
Egypt and Turkey seek to overhaul tense ties with frank talks on Libya
EU considers COVID vaccine patent waiver but Germany, drugmakers push back

Stories You'll Enjoy